High-dose mercaptopurine and intermediate-dose cytarabine during first remission of acute myeloid leukemia

被引:1
|
作者
Canpolat, C [1 ]
Jeha, S [1 ]
Lockhart, S [1 ]
Ramirez, I [1 ]
Zipf, T [1 ]
Pinkel, D [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT PEDIAT,HOUSTON,TX 77030
关键词
D O I
10.3109/07357909709115764
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High-dose, continuous infusion of intravenous mercaptopurine (HD 6MP) followed by intermediate-dose continuous cytarabine (ID Ara-C) has been shown to produce remissions in children with relapsed acute myeloid leukemia (AML). The purpose of this pilot study was to explore the feasibility of using this drug regimen as a component of treatment during the first remission of AML. Of 17 children with newly diagnosed AML registered in the study, 14 developed complete remission on conventional induction therapy and subsequently received the HD 6MP and ID Ara-C combination. The dosages of HD 6MP were escalated from 500 mg/m(2) to 1250 mg/m(2) in 24-hr infusions. The initial dosages of ID Ara-C were escalated from 250 mg/m(2) to 650 mg/m(2)/24 hr and from 1 day to 4 days. Conventional treatment for AML was administered simultaneously. Seven of the 14 children remain in initial complete remission for 15 to 46 months and have completed treatment. Severe pancytopenia was observed in all patients. but there were no toxic deaths and no deaths during remission. The inclusion of HD 6MP and ID Ara-C in the treatment of AML in first remission appears to be feasible. Evaluation of its efficacy will require a comparative clinical trial.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 50 条
  • [41] High-dose cytarabine benefits patients with acute myeloid leukemia and RAS mutations
    不详
    Nature Clinical Practice Oncology, 2009, 6 (1): : 3 - 4
  • [42] MITOXANTRONE AND INTERMEDIATE-DOSE CYTARABINE IN RELAPSED OR REFRACTORY ACUTE MYELOBLASTIC-LEUKEMIA
    HAROUSSEAU, JL
    MILPIED, N
    BRIERE, J
    DESABLENS, B
    GHANDOUR, C
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1990, 32 (04): : 227 - 230
  • [43] Acute cerebellar syndrome following intermediate-dose cytarabine
    Yeshurun, M
    Dupuch, KM
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (04) : 846 - 846
  • [44] EXPERIENCE WITH INTERMEDIATE-DOSE AND HIGH-DOSE CYTOSINE-ARABINOSIDE IN RELAPSED AND REFRACTORY ACUTE-LEUKEMIA
    WILLEMZE, R
    FIBBE, WE
    ZWAAN, FE
    NETHERLANDS JOURNAL OF MEDICINE, 1983, 26 (08): : 215 - 219
  • [45] Comparison of Condensed to Standard Schedule of High Dose Cytarabine Consolidation for Acute Myeloid Leukemia in First Complete Remission
    Solh, Melhem M.
    Kilby, Kristen
    Baron, Jimena
    Zhang, Xu
    Bashey, Asad
    Holland, H. Kent
    Bachier-Rodriguez, Lizamarie
    Morris, Lawrence
    Solomon, Scott R.
    BLOOD, 2023, 142
  • [46] Cytarabine Dose for Acute Myeloid Leukemia
    Lowenberg, Bob
    Pabst, Thomas
    Vellenga, Edo
    van Putten, Wim
    Schouten, Harry C.
    Graux, Carlos
    Ferrant, Augustin
    Sonneveld, Pieter
    Biemond, Bart J.
    Gratwohl, Alois
    de Greef, Georgine E.
    Verdonck, Leo F.
    Schaafsma, Martijn R.
    Gregor, Michael
    Theobald, Matthias
    Schanz, Urs
    Maertens, Johan
    Ossenkoppele, Gert J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (11): : 1027 - 1036
  • [47] Cytarabine Dose for Acute Myeloid Leukemia
    Mori, Jinichi
    Tsubokura, Masaharu
    Kami, Masahiro
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (22): : 2166 - 2167
  • [48] MITOXANTRONE, ETOPOSIDE, AND INTERMEDIATE-DOSE CYTARABINE - AN EFFECTIVE AND TOLERABLE REGIMEN FOR THE TREATMENT OF REFRACTORY ACUTE MYELOID-LEUKEMIA
    AMADORI, S
    ARCESE, W
    ISACCHI, G
    MELONI, G
    PETTI, MC
    MONARCA, B
    TESTI, AM
    MANDELLI, F
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (07) : 1210 - 1214
  • [49] Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia
    Saito, Bungo
    Nakamaki, Tsuyoshi
    Nakashima, Hidetoshi
    Usui, Takako
    Hattori, Norimichi
    Kawakami, Keiichiro
    Tomoyasu, Shigeru
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (04) : 304 - 306
  • [50] Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes
    Jean Galtier
    Camille Alric
    Emilie Bérard
    Thibaut Leguay
    Suzanne Tavitian
    Audrey Bidet
    Eric Delabesse
    Jean Baptiste Rieu
    Jean-Philippe Vial
    François Vergez
    Nicolas Lechevalier
    Isabelle Luquet
    Emilie Klein
    Anne-Charlotte de Grande
    Audrey Sarry
    Arnaud Pigneux
    Christian Récher
    Sarah Bertoli
    Pierre-Yves Dumas
    Blood Cancer Journal, 11